Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats
- 1 September 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (9) , 1193-1197
- https://doi.org/10.1016/0277-5379(84)90129-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in ratsEuropean Journal of Cancer and Clinical Oncology, 1983
- Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivityEuropean Journal of Cancer and Clinical Oncology, 1982
- ESTROGEN, ANDROGEN, GLUCOCORTICOID, AND PROGESTERONE RECEPTORS IN PROGESTIN-INDUCED REGRESSION OF HUMAN-BREAST CANCER1980
- COMPARATIVE EFFECTS OF A SERIES OF PROLACTIN INHIBITORS, 17BETA-ESTRADIOL AND 2ALPHA-METHYLDIHYDROTESTOSTERONE PROPIONATE, ON GROWTH OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY CARCINOMAS1977
- PROLACTIN AND MURINE MAMMARY TUMORIGENESIS - REVIEW1977
- On the Mechanism of Prolactin and Estrogen Action in 7,12 Dimethylbenz(A)anthracene-Induced Mammary Carcimona in the Rat. II.In VivoTumor Responses and Estrogen Receptor1,2,3Endocrinology, 1975
- EFFECTS OF PROGESTINS ON ESTRADIOL RECEPTOR LEVELS IN HUMAN ENDOMETRIUMJournal of Clinical Endocrinology & Metabolism, 1975
- Prolactin and human breast cancerThe American Journal of Surgery, 1974
- Effect of progesterone on human endometrial carcinoma in different experimental systemsActa Obstetricia et Gynecologica Scandinavica, 1972
- Effect of Medroxyprogesterone Acetate (Provera) on the Metabolism and Biological Activity of TestosteroneJournal of Clinical Endocrinology & Metabolism, 1970